We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current OMGA market cap is 142.27M. The company's latest EPS is USD -1.7669 and P/E is -1.46.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 595k | 735k | 516k | 758k | 831k |
| Operating Income | -25.99M | -30.97M | -25.82M | -30.84M | -22.9M |
| Net Income | -25.8M | -30.83M | -25.28M | -29.69M | -22.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 144k | 2.07M | 3.09M |
| Operating Income | -17.34M | -28.65M | -66.03M | -102.77M | -100.26M |
| Net Income | -17.95M | -29.45M | -68.28M | -102.7M | -97.43M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 170.07M | 146M | 156.32M | 229.02M | 217.81M |
| Total Liabilities | 36.41M | 40.03M | 33.32M | 133.1M | 141.77M |
| Total Equity | 133.65M | 105.97M | 123M | 95.92M | 76.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.12M | 28.08M | 233.33M | 146M | 204.37M |
| Total Liabilities | 15.33M | 17.49M | 32.71M | 40.03M | 146.35M |
| Total Equity | -35.92M | -64.63M | 200.63M | 105.97M | 58.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.28M | -98.52M | -28.11M | -51.38M | -74.42M |
| Investing | -35.71M | -18.06M | 22.05M | 46.1M | 45.38M |
| Financing | 122k | 708k | 39.99M | 40.21M | 40.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.68M | -26.13M | -57.61M | -98.52M | -91.51M |
| Investing | -885k | -1.81M | -40.4M | -18.06M | 47.52M |
| Financing | 11.99M | 48.62M | 261.54M | 708k | 41.82M |
| Market Cap | 142.27M |
| Price to Earnings Ratio | -1.46 |
| Price to Sales Ratio | 45.99 |
| Price to Cash Ratio | 2.08 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 55.14M |
| Average Volume (1 week) | 350.45k |
| Average Volume (1 Month) | 320.65k |
| 52 Week Change | -69.18% |
| 52 Week High | 10.09 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 0.11 (4.06%) |
| Company Name | Omega Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.omegatherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
